What's in a (tumor) cavity?

Affiliations

Editorial

Michael J McKay. Transl Lung Cancer Res. 2020 Feb.

. 2020 Feb;9(1):8-9.

doi: 10.21037/tlcr.2019.10.01.

¹ School of Cancer Medicine, La Trobe University, Olivia Newton-John Cancer Research Institute at Austin Campus, Heidelberg, Australia.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Influence and mechanism of lung cavitation development on antiangiogenic therapy.
Jiang M, Zhang C, Liu D, Wang Y, Wang H, Li T, Hou H, Zhou N, Zhu J, Lv H, Zhang C, Fang B, Zhang X. Jiang M, et al. Transl Lung Cancer Res. 2019 Aug;8(4):500-512. doi: 10.21037/tlcr.2019.07.01. Transl Lung Cancer Res. 2019. PMID: 31555522 Free PMC article.

1. Chaudhuri MR. Primary pulmonary cavitating carcinomas. Thorax 1973;28:354-66. 10.1136/thx.28.3.354 - DOI - PMC - PubMed
1. Huang C, Wang X, Wang J, et al. Incidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor. Thorac Cancer 2014;5:438-46. 10.1111/1759-7714.12115 - DOI - PMC - PubMed
1. Marom EM, Martinez CH, Truong MT, et al. Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol 2008;3:351-7. 10.1097/JTO.0b013e318168c7e9 - DOI - PubMed
1. Nishino M, Cryer SK, Okajima Y, et al. Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab. Cancer Imaging 2012;12:225-35. 10.1102/1470-7330.2012.0027 - DOI - PMC - PubMed
1. Crabb SJ, Patsios D, Sauerbrei E, et al. Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer. J Clin Oncol 2009;27:404-10. 10.1200/JCO.2008.16.2545 - DOI - PubMed